The role of thrombospondin-1 in tumor progression and angiogenesis

BioEssays

Volumn 18, Issue 1, 1996, Pages 71-76

  Tuszynski, George P ^a   Nicosia, Roberta F ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; MEMBRANE PROTEIN; THROMBOSPONDIN; TUMOR PROTEIN;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL; AORTA; ARTICLE; BIOLOGICAL MODEL; CANCER INVASION; CELL ADHESION; CORNEA; CYTOLOGY; DISEASE COURSE; DRUG EFFECT; EXPERIMENTAL NEOPLASM; HUMAN; METABOLISM; MOLECULAR GENETICS; MOUSE; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RABBIT; RAT; VASCULAR ENDOTHELIUM; VASCULARIZATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD36; AORTA; CELL ADHESION; CORNEA; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RABBITS; RATS; THROMBOSPONDINS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0030040976     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.950180113     Document Type: Article

References (57)

1. Tuszynski, G.P. et al. (1987). Thrombospondin promotes cell-substratum adhesion. Science 236, 1570-1573.
2. Lawler, J., Weinstein, R. and Hynes, R.O. (1988). Cell attachment to thrombospondin: The role of ARG-GLY-ASP, calcium, and integrin receptors. J. Cell Biol. 107, 2351-2381.
3. Morandi, V., Fauvel-Lafeve, F., Legrand, C. and Legrand, Y.J. (1993). Role of thrombospondin in the adhesion of human endothelial cells in primary culture. In Vitro Cell. Dev. Biol. 29A, 585-591.
4. Tuszynski, G.P. (1993). The Role of Thrombospondin in Tumor Cell Metastasis (ed. J. Lahav), pp. 209-221. Boca Raton, Fl: The CRC Press, Inc.
5. Mosher, D.F. (1990). Physiology of thrombospondin. Annu. Rev. Med. 41, 85-97.
6. Taraboletti, G., Roberts, D.D. and Liotta, L.A. (1987). Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains. J. Cell Biol. 105, 2409-2415.
7. Yabkowitz, R., Mansfield, P.J., Dixit, V.M. and Suchard, S.J. (1993). Motility of human carcinoma cells in response to thrombospondin: Relationship to metastatic potential and thromboapondin structural domains. Cancer Res. 53, 378-387.
8. Wang, T.N., Qian, X., Garnick, M.S., Solomon, M.P., Rothman, V.L. and Tuszynaki, G.P. (1995). The effect of thrombospondin (TSP) on oral squamous carcinoma cell invasion of collagen. Am J. Surg. (in press).
9. Wang, T.N., Qian, X., Rothman, V.L., Solomon, M.P., Granick, M.S. and Tuszynski, G.P. (1995). The effect of thrombospondin (TSP) on breast and oral carcinoma cell invasion of collagen. Cancer Res. 36, 75.
10. Castle, V., Varani, J., Fligiel S., Prochownik, E.V. and Dixit, V. (1991). Antisense-medtatod reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma. J. Clin. Invest. 87, 1883-1888.
11. Weinstat-Saslow, D.L., Zabrenetzky, V.S., VanHoutte, K., Frazier, W.A., Roberts, D.D. and Steeg, P.S. (1994). Transtaction of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res. 54, 6504-6511.
12. Tuszynski, G.P., Gasic, T.B., Rothman, V.L., Knudsen, K.A. and Gasic, G.J. (1987). Thrombospondin, a potentiator of tumor cell metastasis. Cancer Res. 47, 4130-4133.
13. Tuszynski, G.P., Rothman, V.L., Deutch, A.H., Hamilton, B.K. and Eyal, J. (1992). Biological activities of peptides and peptide analogues derived from common sequences present in thrombospondin, properdin, and malarial proteins. J. Cell Biol. 116, 209-217.
14. Tuszynski, G.P., Rothman, V.L., Papale, M., Hamilton, B.K. and Eyal, J. (1993). Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain. J. Cell Biol. 120, 513-521.
15. Asch, A.S. et al. (1993). Analysis of CD36 binding domains: Ligand specificity controlled by dephosphorylation of an ectodomain. Science 262, 1436-1440.
16. Clezardin, P., Frappart, L., Clerget, M., Pechoux, C. and Delmas, P.D. (1993). Expression of thrombospondin (TSP-1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast. Cancer Res. 53, 1421-1430.
17. Pratt, D.A., Miller, W.R. and Dawes, J. (1989). Thrombospondin in malignant and non-malignant breast tissue. Eur. J. Cancer Clin. Oncol. 25, 343-350.
18. Wong, S.Y., Purdie, A.T. and Han, P. (1992). Thrombospondin and other possible related matrix proteins in malignant and benign breast disease: An immunohistochemical study. Am. J. Pathol. 140, 1473-1482.
19. Tuszynski, G.P. and Nicosia, R.F. (1994). Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma. Lab. Invest. 70, 228-233.
20. Arnoletti, J.P. et al. (1994). Computer-assisted image analysis of tumor sections for a new thrombospondin receptor. Am. J. Surg. 168, 433-436.
21. Hosokawa, T., Muraishi, A., Rothman, V.L., Papale, M. and Tuszynski, G.P. (1993). The effect of thrombospondin on invasion of fibrin gels by human A549 lung carcinoma. Oncol. Res. 5, 183-189.
22. Albo, D. et al. (1994). Thrombospondin (TSP-1) and transforming growth factor beta 1 (TGF-β) promote human A549 lung carcinoma cell plasminogen activator inhibitor type 1 (PAI-1) production and stimulate tumor cell attachment in vitro. Biochem. Biophys. Res. Commun. 203, 857-865.
23. Arnoletti, J.P., Albo, D., Granick, M.S., Solomon, M.P., Rothman, V.L. and Tuszynaki, G.P. (1994). Thrombospondin and transforming growth factor beta 1 increase expression of urokinase type plasminogen activator and plasminogen activator inhibitor 1 in human MDA-MB-231 breast cancer cells. Cancer (in press).
24. Moscatelli, D. and Rifkin, D.B. (1994). Membrane and matrix localization of proteases: a common theme in tumor cell invasion and angiogenesis. Biochem. Biophys. Acta 948, 67-85.
25. Tuszynski, G.P. et al. (1992). Thrombospondin levels in patients with malignancy. Thromb. Haemost. 67, 607-611.
26. Nathan, F.E. et al. (1994). Plasma thrombospondin levels in patients with gynecologic malignancies. Cancer 73, 2853-2858.
27. Folkman, J. (1976). Vascularization of tumors. Sci. Am. 234, 58-73.
28. Weidner, N.J., Semple, J.P., Welch, W.R. and Folkman, J. (1991). Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 324, 1-8.
29. Raugi, G.J., Olerud, J.E. and Gown, A.M. (1987). Thrombospondin in early human wound tissue. J. Invest. Dermatol. 89, 551-554.
30. Miano, J.M., Vlasic, N., Tota, R.R. and Stemerman, N.B. (1993). Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury. Arteriosclerosis and Thrombosis 13, 211-219.
31. DiPietro, L.A. and Polverini, P.J. (1993). Angiogenic macrophages produce the angtogenic inhibitor thrombospondin 1. Am. J. Pathol. 143, 678-684.
32. Canfield, A.E., Boot-Handford, R.P. and Scher, A.M. (1990). Thrombospondin gene expression by endothelial cells in culture is modulated by cell proliferation, cell shape and the substratum. Biochem. J. 268, 225-230.
33. BenEzra, D., Griffin, B.W., Maftzir, G. and Aharonov, O. (1983). Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide. Invest. Ophthalmol. Vis. Sci. 34, 3601-3608.
34. Dameron, K.M., Volpert, O.V., Tainsky, M.A. and Bouck, N. (1994). Control or angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265, 1582-1584.
35. Good, D.J. et al. (1990). A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionary indistinguishable from a fragment of thrombospondin. Proc. Natl Acad. Sci. USA 87, 6624-6628.
36. Tolsma, S.A., Volpert, O.G. Good, D.J., Frazier, W.A., Polverini, P.J. and Bouck, N. (1993). Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell Biol. 122, 497-511.
37. Taraboletti, G.D., Balotti, D. and Giavazzi, R. (1992). Thrombospondin modulates basic fibroblast growth factor activities on endothelial cells. EXS 61, 210-213.
38. Nicosia, R.F. and Tuszynski, G.P. (1994). Matrix-bound thrombospondin promotes angiogenesis in vitro. J. Cell Biol. 124, 183-193.
39. Taraboletti, G., Roberts, D., Liotta, L.A. and Giavazzi, R. (1990). Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J. Cell Biol. 111, 765-772.
40. Bagavandoss, P. and Wilks, J.W. (1990). Specific inhibition of endothelial cell proliferation by thrombospondin. Biochem. Biophys. Res. Commun. 170, 867-872.
41. Bagavandoss, P., Kaytes, P., Vogeli, G., Wells, P.A. and Wilks, J.W. (1993). Recombinant truncated thrombospondin-1 monomer modulates endothelial cell plasminogen activator inhibitor 1 accumulation and proliferation in vitro. Biochem. Biophys. Res. Commun. 192, 325-332.
42. Lahav, J. (1988). Thrombospondin inhibits adhesion of endothelial cells. Exp. Cell Res. 177, 199-204.
43. Murpny-Ullrich, J.E. and Hook, M. (1989). Thrombospondin modulates focal adhesions in endothelial cells. J. Cell Biol. 109, 1309-1319.
44. Nicosia, R.F., Tchao, R. and Leighton, J. (1983). Angiogenesis-dependent tumor spread in reinforced fibrin clot culture. Cancer Research 43, 2159-2166.
45. Folkman, J. and Shing, Y. (1992). Angiogenesis. J. Biol. Chem. 267, 10931-10934.
46. Iruela-Arispe, M.L., Bornstein, P. and Sage, H. (1991). Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc. Natl Acad. Sci. USA 88, 5026-5030.
47. Vernon, R.B. et al. (1995). Organized type 1 collagen influences endothelial patterns during 'spontaneous angiogeneous in vitro': planar cultures as models of vascular development. In vitro Cell. Dev. Biol. 31, 120-31.
48. Qian, X., Nicosia, R.F., Bochenek, K.M., Rothman, V.L. and Tuszynski, G.P. (1994). The effect of thrombospondin on endothelial cell tube formation in vitro. Mol. Biol. Cell 5, 179a.
49. RayChaudhury, A., Frazier, W.A. and D'Amore, P.A. (1994). Comparison of normal and tumorigenic endothelial cells: Differences in thrombospondin production and responses to transforming growth factor-beta. J. Cell Sci. 107, 39-46.
50. Sheibani, N. and Frazier, W.A. (1995). Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis. Proc. Natl Acad. Sci. USA 92, 6788-6792.
51. Mansfield, P.J. and Suchard, S.J. (1994). Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes. J. Immunol. 153, 4219-4229.
52. Phan, S.H., Dillon, R.G., McGarry, B.M. and Dixit, V.M. (1989). Stimulation of fibroblast proliferation by thrombospondin. Biochem. Biophys. Res. Commun. 163, 56-63.
53. Majack, R.A., Goodman, L.V. and Dixit, V.M. (1988). Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J. Cell Biol. 106, 415-422.
54. Schultz-Cherry, S. and Murphy-Ullrich, J.E. (1993). Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J. Cell Biol. 122, 923-932.
55. Schultz-Cherry, S., Ribeiro, S., Gentry, L. and Murphy-Ullrich, J.E. (1994). Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically defined system. J. Biol. Chem. 269, 26775-26782.
56. Schultz-Cherry, S., Lawler, J. and Murphy-Ullrich, J.E. (1994). The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-β. J. Biol. Chem. 269, 26783-26788.
57. Majack, R.A., Majesky, M.W. and Goodman, L.V. (1990). Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta. J. Cell Biol. 111, 239-247.